Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Faron Pharmaceutical (Finland) | Researchclopedia

Back to institutions

Faron Pharmaceutical (Finland)

Turkucompany

75

Works

2,005

Citations

20

h-index

Top Research Topics

Immune cells in cancer Acute Myeloid Leukemia Research Cancer Immunotherapy and Biomarkers

Top Researchers

Petri Bono Faron Pharmaceutical (Finland)

278 works19,636 citationsh-index: 53

Recent Research

Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs

Amer M Zeidan,Sofia Aakko,et al.

20260 citations

Immune Response and Inflammation

Respiratory Support and Mechanisms

Pharmaceutical Economics and Policy

COVID-19 Clinical Research Studies

Monoclonal and Polyclonal Antibodies Research

Myeloproliferative Neoplasms: Diagnosis and Treatment

Phagocytosis and Immune Regulation

Immunotherapy and Immune Responses

Chronic Myeloid Leukemia Treatments

Markku Jalkanen

158 works8,858 citationsh-index: 49

615 works6,619 citationsh-index: 39

281 works6,452 citationsh-index: 42

Jussi Koivunen Oulu University Hospital

172 works5,572 citationsh-index: 30

Jon Williamson University of Manchester

221 works4,856 citationsh-index: 34

P06.06 Clever-1 blockade as a potential immunomodulatory treatment for brain tumors

R Suresh,Rita Turpin,et al.

20260 citations

Targeting CD73 and correcting adenosinergic signaling in critically ill patients

Justin Mark Lunderberg,Alexander James Spicer,et al.

20261 citations

Clinical optimization of bexmarilimab as a myeloid checkpoint therapy

Mahalakshmi Karthikeyan,Jesper Mickos,et al.

20250 citations

Female Mice with HSD17B1 Inactivation Show Mild Hyperandrogenism without Notable Impact on Reproductive Function or Bone

Arttu Junnila,Nataliia Petruk,et al.

20251 citations

Efficacy, molecular and translational analysis of TP53-mutated HR-MDS with bexmarilimab and azacitidine: Updated results from the bexmab Phase 1/2 study

Amer M. Zeidan,Anthony S. Stein,et al.

20253 citations